ID   WEHI-3B D+
AC   CVCL_4357
SY   WEHI-3B(D+); WEHI-3BD; WEHI 3BD
DR   CLO; CLO_0009570
DR   CLO; CLO_0009581
DR   CLDB; cl4693
DR   CLDB; cl4694
DR   ECACC; 92110401
DR   Wikidata; Q54993762
RX   CelloPub=CLPUB00272;
RX   PubMed=2824536;
RX   PubMed=8642845;
CC   Transformant: DrugBank; DB11057; Mineral oil.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Breed/subspecies: BALB/c.
DI   NCIt; C21604; Mouse leukemia
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2239 ! WEHI-3B
SX   Male
AG   6M
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
RX   CelloPub=CLPUB00272;
RA   Pessina A., Mineo E., Gribaldo L., Mancina G., Neri M.G., Moran E.,
RA   Cleary I., Clynes M.;
RT   "Susceptibility of leukemia cell lines to quinolones and induction of
RT   resistance to ciprofloxacin in WEHI-3B(D+) leukemia cells.";
RL   Cancer J. 6:291-297(1993).
//
RX   PubMed=2824536; DOI=10.1002/jcp.1041330404;
RA   Nicola N.A.;
RT   "Hemopoietic growth factors and their interactions with specific
RT   receptors.";
RL   J. Cell. Physiol. Suppl. 5:9-14(1987).
//
RX   PubMed=8642845; DOI=10.1016/0145-2126(95)00141-7;
RA   Hayashi M., Tomida M., Hozumi M., King I.C., Sartorelli A.C.;
RT   "Detection of in vivo differentiation of murine WEHI-3B D+ leukemia
RT   cells transfected with the lac-Z marker gene using two-color flow
RT   cytometry.";
RL   Leuk. Res. 20:333-341(1996).
//